Piramal Pharma#39;s Rs 1,050 crore rights issue gets Sebi#39;s nod

Piramal Pharma#39;s Rs 1,050 crore rights issue gets Sebi#39;s nod The pharma firm, which filed draft papers with the regulator in March, obtained its observation letter on July 12, an update with the Securities and Exchange Board of India (Sebi) showed on Tuesday.

from Moneycontrol Business News https://ift.tt/ZxNXMmS
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...